Venezuela Unveils Amnesty Bill For Mass Release Of Political Prisoners Venezuela's US-backed and CIA-installed interim president Delcy Rodriguez has unveiled a sweeping amnesty bill that could pave the way for the release of hundreds of detainees, in a first major political move since former President Nicolas Maduro and his wife were ousted and whisked off to New York earlier this month. "We have ...
Venezuela Unveils Amnesty Bill For Mass Release Of Political Prisoners Venezuela's US-backed and CIA-installed interim president Delcy Rodriguez has unveiled a sweeping amnesty bill that could pave the way for the release of hundreds of detainees, in a first major political move since former President Nicolas Maduro and his wife were ousted and whisked off to New York earlier this month. "We have decided to push ahead with a general amnesty law that covers the whole period of political violence from 1999 to the present day ," Rodriguez announced Friday. She issued her address before a who's who of government figures, including judges and federal magistrates, that the National Assembly would take up the bill "with urgency". There are believed to currently be at least 700 inmates deemed political prisoners nationwide. via Associated Press "May this law serve to heal the wounds left by the political confrontation fueled by violence and extremism ," Rodriguez said in the televised address. "May it serve to redirect justice in our country, and may it serve to redirect coexistence among Venezuelans," she added. Rodriguez has also declared the closure of El Helicoide, the notorious Caracas detention center run by the intelligence services, long accused by former inmates and independent rights groups of torture and systemic abuse. The plan is to change it into a sports, social, and cultural complex serving nearby neighborhoods - though surely the country will still maintain its necessary and regular prison system. Hopefully, Caracas and the US are also being somewhat selective on who they let walk free, given there could be hardened violent criminals and assassins in the mix. A little over a week after the US incursion into Venezuela and change of government, the head of the country's National Assembly, Jorge Rodríguez, had first announced the release of a "significant number" of political prisoners. Under Washington pressure, one prominent name among those freed was the fo...
Jarrell “Big Baby” Miller was involved in one of the more unusual moments in recent boxing history on Saturday night when his hairpiece was dislodged during his heavyweight victory over Kingsley Ibeh on the undercard of the Teófimo López–Shakur Stevenson card at Madison Square Garden. The incident occurred late in the second round as Ibeh landed a flurry of punches along the ropes. One shot snappe...
Jarrell “Big Baby” Miller was involved in one of the more unusual moments in recent boxing history on Saturday night when his hairpiece was dislodged during his heavyweight victory over Kingsley Ibeh on the undercard of the Teófimo López–Shakur Stevenson card at Madison Square Garden. The incident occurred late in the second round as Ibeh landed a flurry of punches along the ropes. One shot snapped Miller’s head backward and caused his hairpiece to lift from the front, briefly exposing a large bald patch before the wig folded backward. The sequence drew gasps and laughter from the crowd. Miller finished the round with the hairpiece still partially attached. Between rounds, he removed it completely in his corner and tossed it into the crowd before returning for the third round. He appeared to laugh off the incident and continued the fight without interruption. The bout continued as scheduled, with officials not stopping the action during the sequence. Miller went on to win a narrow split decision by scores of 97-93, 97-93 and 94-96. After the decision was announced, he rubbed the top of his head while celebrating in the ring. Speaking afterward, Miller joked that he had lost much of his hair only days earlier after using a bottle of shampoo he said he found at his mother’s house. "He slapped that s*** off." Jarrell Miller reacts to losing his hair during his win over Kingsley Ibeh 🤣 The Ring VI | Buy now at https://t.co/AxmwuHu4GB 🥊 pic.twitter.com/yM7Ix8zOQK — Ring Magazine (@ringmagazine) February 1, 2026 Miller, 37, has remained a semi-active and controversial figure in boxing. He was originally scheduled to face then-champion Anthony Joshua at MSG in 2019 before being removed from the bout after failing multiple pre-fight drug tests. Joshua instead fought late replacement Andy Ruiz Jr, who stopped him in one of the sport’s biggest ever upsets. Miller later returned to the sport after serving suspensions related to anti-doping violations and has since worked to re...
Key Points Sandip Kapadia sold 20,961 shares for a transaction value of approximately $752,800 on Jan. 15, 2026. Harmony Biosciences reported strong Q3 2025 earnings and expects to generate $1 billion in revenue from one of its top products. These 10 stocks could mint the next wave of millionaires › Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (NASDAQ:HRMY), executed an open-mark...
Key Points Sandip Kapadia sold 20,961 shares for a transaction value of approximately $752,800 on Jan. 15, 2026. Harmony Biosciences reported strong Q3 2025 earnings and expects to generate $1 billion in revenue from one of its top products. These 10 stocks could mint the next wave of millionaires › Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (NASDAQ:HRMY), executed an open-market sale of 20,961 directly held shares on Jan. 15, 2026, fully exiting direct equity ownership, according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 20,961 Transaction value ~$752,800 Post-transaction shares (direct) 0 Transaction value based on SEC Form 4 weighted average purchase price ($35.92). Key questions How significant was this transaction in the context of Kapadia’s historical selling activity? This sale fully liquidated Kapadia’s remaining direct position, following a series of prior dispositions over the past year that cumulatively reduced direct holdings from 72,948 shares to zero. This sale fully liquidated Kapadia’s remaining direct position, following a series of prior dispositions over the past year that cumulatively reduced direct holdings from 72,948 shares to zero. How does the transaction price compare to the market price at the time of the sale? The weighted-average sale price was around $35.92 per share, slightly below the market close of $36.41 on Jan. 15, 2026, and below the current share price of $36.62 as of Jan. 31, 2026. Company overview Metric Value Price (as of Jan. 31, 2026) $35.52 Market capitalization $2.1 billion Revenue (TTM) $825.94 million Net income (TTM) $185.68 million Company snapshot Harmony Biosciences is a U.S.-based biopharmaceutical company specializing in the development and commercialization of therapies for rare neurological diseases. One of its most successful therapies is WAKIX, a pharmaceutical product that addresses narcolepsy. What this transaction means for investors The shares Kapadia...
Former senior Microsoft Corp. executive Steven Sinofsky sought Jeffrey Epstein’s advice as he negotiated the terms of his exit from the company and worked through what to do next, according to documents made public by the Justice Department . Sinofsky, who is now a board partner with venture capital firm Andreessen Horowitz, was long one of Microsoft’s most prominent executives. He abruptly left t...
Former senior Microsoft Corp. executive Steven Sinofsky sought Jeffrey Epstein’s advice as he negotiated the terms of his exit from the company and worked through what to do next, according to documents made public by the Justice Department . Sinofsky, who is now a board partner with venture capital firm Andreessen Horowitz, was long one of Microsoft’s most prominent executives. He abruptly left the software maker in late 2012 after the release of Windows 8. The following June, he and Microsoft negotiated a retirement agreement that contained non-compete and non-solicitation clauses, and established the stock grants Sinofsky would be entitled to receive. In between, Sinofsky sought Epstein’s advice on talks with the company and public relations strategy, and forwarded correspondence from his personal attorney, as well as from Microsoft’s then general counsel, Brad Smith, and journalists . “I gotta sleep...but advise me or tell me who to advise me?” Sinofsky wrote in a December 2012 email to Epstein. Sinofsky and a spokesperson for Microsoft declined to comment. Representatives of Andreessen Horowitz did not respond to a request for comment. Sinofsky has been with the firm since August 2013, according to his LinkedIn page, a role he describes as a contract post in which he serves on boards and advises portfolio companies. The exchanges between the two are included among millions of pages of additional material that the Justice Department released Friday related to investigations of the disgraced, late financier. Epstein’s relationship with Microsoft co-founder Bill Gates, who appears in images contained in earlier document releases, has also come under scrutiny. Many of the emails between Epstein and Sinofsky were sent as early as 2012, four years after Epstein pleaded guilty to Florida state charges that included procurement of minors to engage in prostitution, and as late as 2017, two years before Epstein was later charged with sex trafficking of minors in 2019. It...
Data analytics company Palantir Technologies (NASDAQ:PLTR) will be reporting results this Monday after market close. Here’s what you need to know. Palantir Technologies beat analysts’ revenue expectations by 8% last quarter, reporting revenues of $1.18 billion, up 62.8% year on year. It was a stunning quarter for the company, with an impressive beat of analysts’ EBITDA estimates and revenue guidan...
Data analytics company Palantir Technologies (NASDAQ:PLTR) will be reporting results this Monday after market close. Here’s what you need to know. Palantir Technologies beat analysts’ revenue expectations by 8% last quarter, reporting revenues of $1.18 billion, up 62.8% year on year. It was a stunning quarter for the company, with an impressive beat of analysts’ EBITDA estimates and revenue guidance for next quarter exceeding analysts’ expectations. Is Palantir Technologies a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, analysts are expecting Palantir Technologies’s revenue to grow 62% year on year to $1.34 billion, improving from the 36% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.23 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Palantir Technologies has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 4.4% on average. Looking at Palantir Technologies’s peers in the data and analytics software segment, only Commvault has reported results so far. It beat analysts’ revenue estimates by 4.9%, delivering year-on-year sales growth of 19.5%. The stock was down 30.5% on the results. Read our full analysis of Commvault’s earnings results here Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the data and analytics software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 10.9% on average over the last month. Palantir Technologies is down 12.3% during the same time and is heading into earnings with an average analyst price target of $189.84 (compared to the current share...
An overreliance on government contracts is turning out to be a headwind for BigBear.ai. BigBear.ai (BBAI 8.70%) has lately been popular among investors looking to buy artificial intelligence (AI) software stocks at reasonable valuations. That's not too surprising, as the company seems to be following Palantir Technologies' (PLTR 3.47%) playbook in the generative AI software market. Palantir initia...
An overreliance on government contracts is turning out to be a headwind for BigBear.ai. BigBear.ai (BBAI 8.70%) has lately been popular among investors looking to buy artificial intelligence (AI) software stocks at reasonable valuations. That's not too surprising, as the company seems to be following Palantir Technologies' (PLTR 3.47%) playbook in the generative AI software market. Palantir initially made its name by supplying analytics solutions to U.S. intelligence agencies and the Defense Department, and its software platforms are still being used by the U.S. Army and the Air Force, as well as Homeland Security, among others. But nearly three years ago, it launched its Artificial Intelligence Platform (AIP) for both commercial and government customers, and since then, its growth has surged, and the stock price has exploded. As a result, it's now trading at exorbitant valuations. Given that BigBear.ai is also targeting both government and commercial customers with a generative AI software platform, it is easy to understand why it, too, has caught investors' attention. The stock has appreciated by 142% over the past three years. However, a closer look at their respective businesses suggests that Palantir is the better long-term bet of the two for investors. The commercial segment has bolstered Palantir's growth Palantir's pivot to seek more of its growth among corporate customers is reaping rich rewards. In the third quarter of 2025, its commercial revenue spiked by 73% year over year to $548 million. Its government revenue rose by 55%. Expand NASDAQ : PLTR Palantir Technologies Today's Change ( -3.47 %) $ -5.27 Current Price $ 146.59 Key Data Points Market Cap $349B Day's Range $ 145.14 - $ 151.00 52wk Range $ 66.12 - $ 207.52 Volume 47M Avg Vol 45M Gross Margin 80.81 % Overall, its top line increased by 63% to $1.18 billion, 46% of which came from commercial customers. It won't be surprising to see the commercial business move the needle more for Palantir in the ...
BigBear.ai (NYSE: BBAI) has lately been popular among investors looking to buy artificial intelligence (AI) software stocks at reasonable valuations. That's not too surprising, as the company seems to be following Palantir Technologies ' (NASDAQ: PLTR) playbook in the generative AI software market. Palantir initially made its name by supplying analytics solutions to U.S. intelligence agencies and ...
BigBear.ai (NYSE: BBAI) has lately been popular among investors looking to buy artificial intelligence (AI) software stocks at reasonable valuations. That's not too surprising, as the company seems to be following Palantir Technologies ' (NASDAQ: PLTR) playbook in the generative AI software market. Palantir initially made its name by supplying analytics solutions to U.S. intelligence agencies and the Defense Department, and its software platforms are still being used by the U.S. Army and the Air Force, as well as Homeland Security, among others. But nearly three years ago, it launched its Artificial Intelligence Platform (AIP) for both commercial and government customers, and since then, its growth has surged, and the stock price has exploded. As a result, it's now trading at exorbitant valuations . Given that BigBear.ai is also targeting both government and commercial customers with a generative AI software platform, it is easy to understand why it, too, has caught investors' attention. The stock has appreciated by 142% over the past three years. Continue reading
Key Points Both stocks have lost value over the last year due to concerns about consumer spending and the threat of caps on credit card fees. Mastercard and Visa are growing revenue and earnings at a solid pace. Both companies generate gobs of free cash flow and return it to shareholders through buybacks and dividends. 10 stocks we like better than Mastercard › The S&P 500 (SNPINDEX: ^GSPC) is up ...
Key Points Both stocks have lost value over the last year due to concerns about consumer spending and the threat of caps on credit card fees. Mastercard and Visa are growing revenue and earnings at a solid pace. Both companies generate gobs of free cash flow and return it to shareholders through buybacks and dividends. 10 stocks we like better than Mastercard › The S&P 500 (SNPINDEX: ^GSPC) is up 14.9% over the last year, but payment processors Mastercard (NYSE: MA) and Visa (NYSE: V) are down slightly. Both stocks have sold off so far in 2026 as investors grow concerned about weakening consumer spending and the Trump administration's proposed 10% cap on credit card interest rates. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Visa and Mastercard reported quarterly earnings on Jan. 29. Here are the key takeaways and why both stocks are great buys on the dip. Strong results from Mastercard and Visa In their earnings releases, Mastercard and Visa both credited solid consumer spending for their record results -- challenging the narrative that consumer spending is under pressure. Mastercard's revenue jumped 18%, and Visa's rose 15%. Mastercard's operating income grew by 25%, far faster than the 10% increase in operating expenses as operating margins grew to 55.8% and diluted earnings per share (EPS) jumped 24%. Visa's operating margin was even better at 61.8%, but its non-GAAP (adjusted) EPS increased by 15% -- less than Mastercard. Both companies reported high-single-digit to low-double-digit increases in payment volume and frequency. Mastercard and Visa make money every time their cards are swiped, tapped, or processed digitally. The fee structure is based on frequency and a percentage of total sales. So both companies are somewhat recession-resistant, in the sense that they will still do well as long as consumers use their cards rather than alte...
This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026. Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (HRMY 0.92%), executed an open-market sale of 20,961 directly held shares on Jan. 15, 2026, fully exiting direct equity ownership, according to a SEC Form 4 filing. Transaction summary Metri...
This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026. Sandip Kapadia, Chief Financial Officer of Harmony Biosciences (HRMY 0.92%), executed an open-market sale of 20,961 directly held shares on Jan. 15, 2026, fully exiting direct equity ownership, according to a SEC Form 4 filing. Transaction summary Metric Value Shares sold (direct) 20,961 Transaction value ~$752,800 Post-transaction shares (direct) 0 Transaction value based on SEC Form 4 weighted average purchase price ($35.92). Key questions How significant was this transaction in the context of Kapadia’s historical selling activity? This sale fully liquidated Kapadia’s remaining direct position, following a series of prior dispositions over the past year that cumulatively reduced direct holdings from 72,948 shares to zero. This sale fully liquidated Kapadia’s remaining direct position, following a series of prior dispositions over the past year that cumulatively reduced direct holdings from 72,948 shares to zero. How does the transaction price compare to the market price at the time of the sale? The weighted-average sale price was around $35.92 per share, slightly below the market close of $36.41 on Jan. 15, 2026, and below the current share price of $36.62 as of Jan. 31, 2026. Company overview Metric Value Price (as of Jan. 31, 2026) $35.52 Market capitalization $2.1 billion Revenue (TTM) $825.94 million Net income (TTM) $185.68 million Company snapshot Harmony Biosciences is a U.S.-based biopharmaceutical company specializing in the development and commercialization of therapies for rare neurological diseases. One of its most successful therapies is WAKIX, a pharmaceutical product that addresses narcolepsy. What this transaction means for investors The shares Kapadia sold were part of a Rule 10b5-1 trading plan, so they were planned in advance, and we can’t truly determine why she decided to fully exit from her equity ...
Key Points EV growth over the next decade could reshape the global automotive industry. Nio's two newer brands are pushing deliveries higher, but its margins are also rising. Lucid's production ramp finally accelerated during the fourth quarter, but financial challenges remain. 10 stocks we like better than Nio › 2025 wasn't an easy year for investors within the electric vehicle (EV) industry. The...
Key Points EV growth over the next decade could reshape the global automotive industry. Nio's two newer brands are pushing deliveries higher, but its margins are also rising. Lucid's production ramp finally accelerated during the fourth quarter, but financial challenges remain. 10 stocks we like better than Nio › 2025 wasn't an easy year for investors within the electric vehicle (EV) industry. The U.S. government administration rolled back incentives such as the $7,500 federal EV tax credit, added tariffs to imported vehicles and automotive parts, and undermined emissions regulations. Many automakers pulled back on previous hefty EV investment plans, taking billions in special charges. Lucid Motors (NASDAQ: LCID) and Nio (NYSE: NIO) took those speed bumps in stride and have serious momentum heading into 2026 -- but does it make them buys now? Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » A Chinese angle Investors interested in scooping up shares of EV makers might start their discovery process with Chinese companies. That's because thanks to government subsidies, joint ventures, and a high rate of domestic EV adoption, Chinese EV makers are well advanced in technology and software, and can undercut almost all competitors on pricing. If investors are looking at the Chinese EV industry, Nio should be at the top of the list of companies to begin researching. The Chinese EV maker has serious momentum after setting a new monthly record for deliveries in December, with a 54.6% gain to 48,135 vehicles, compared to the prior year. Delivery growth for the fourth quarter was even better, with a 71.7% year-over-year gain to 124,807 vehicles. The explosive delivery growth was noticeable when graphed. The good news is that there's still room for growth. In fact, Nio's two newer brands, Onvo and Firefly, only generated roughly one-third of Nio's December del...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Corning (NYSE:GLW) has entered a multiyear agreement to supply advanced optical fiber and cable to Meta Platforms for its next generation AI data centers. The deal includes a major manufacturing expansion in North Carolina to su...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Corning (NYSE:GLW) has entered a multiyear agreement to supply advanced optical fiber and cable to Meta Platforms for its next generation AI data centers. The deal includes a major manufacturing expansion in North Carolina to support Meta's growing AI infrastructure needs. The partnership reinforces Corning's role in global AI connectivity and domestic high tech manufacturing. For investors watching NYSE:GLW, this agreement comes after a strong run in the share price, with the stock at $103.25 and up 10.7% over the past week, 13.9% over the past month, and 102.0% over the past year. The performance over 3 and 5 years, up 213.9% and 216.6% respectively, highlights how central optical communications have become to Corning's story. This Meta agreement ties Corning more closely to AI data center build outs, an area many investors are watching closely. It may also draw more attention to how Corning's optical communications segment and U.S. manufacturing footprint fit into broader themes around AI connectivity and domestic supply chains. Stay updated on the most important news stories for Corning by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Corning. NYSE:GLW Earnings & Revenue Growth as at Feb 2026 How Corning stacks up against its biggest competitors Quick Assessment ⚖️ Price vs Analyst Target : At US$103.25, Corning trades about 10% below the US$114.46 analyst consensus target. ✅ Simply Wall St Valuation : Simply Wall St estimates the shares are trading roughly 14.6% below fair value. ✅ Recent Momentum: The 30 day return of about 13.9% signals strong short term momentum into this Meta agreement. Check out Simply Wall St's in depth valuation analysis for Corning. Key Considerations 📊 The Meta AI data center contract ties Corning more ...